These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 16229802)

  • 1. Epigenetic regulation of the cell type-specific gene 14-3-3sigma.
    Oshiro MM; Futscher BW; Lisberg A; Wozniak RJ; Klimecki WT; Domann FE; Cress AE
    Neoplasia; 2005 Sep; 7(9):799-808. PubMed ID: 16229802
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CpG island promoter methylation and silencing of 14-3-3sigma gene expression in LNCaP and Tramp-C1 prostate cancer cell lines is associated with methyl-CpG-binding protein MBD2.
    Pulukuri SM; Rao JS
    Oncogene; 2006 Aug; 25(33):4559-72. PubMed ID: 16786000
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of 14-3-3sigma expression in human thyroid carcinoma is epigenetically regulated by aberrant cytosine methylation.
    Lal G; Padmanabha L; Provenzano M; Fitzgerald M; Weydert J; Domann FE
    Cancer Lett; 2008 Aug; 267(1):165-74. PubMed ID: 18440129
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Frequent 14-3-3 sigma promoter methylation in benign and malignant prostate lesions.
    Henrique R; Jerónimo C; Hoque MO; Carvalho AL; Oliveira J; Teixeira MR; Lopes C; Sidransky D
    DNA Cell Biol; 2005 Apr; 24(4):264-9. PubMed ID: 15812243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostate cancer is characterized by epigenetic silencing of 14-3-3sigma expression.
    Lodygin D; Diebold J; Hermeking H
    Oncogene; 2004 Dec; 23(56):9034-41. PubMed ID: 15489902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigenetic and proteolytic inactivation of 14-3-3sigma in breast and prostate cancers.
    Horie-Inoue K; Inoue S
    Semin Cancer Biol; 2006 Jun; 16(3):235-9. PubMed ID: 16682214
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Downregulation of 14-3-3sigma in ovary, prostate and endometrial carcinomas is associated with CpG island methylation.
    Mhawech P; Benz A; Cerato C; Greloz V; Assaly M; Desmond JC; Koeffler HP; Lodygin D; Hermeking H; Herrmann F; Schwaller J
    Mod Pathol; 2005 Mar; 18(3):340-8. PubMed ID: 15257317
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction of 5-aza-2'-deoxycytidine and depsipeptide on antineoplastic activity and activation of 14-3-3sigma, E-cadherin and tissue inhibitor of metalloproteinase 3 expression in human breast carcinoma cells.
    Gagnon J; Shaker S; Primeau M; Hurtubise A; Momparler RL
    Anticancer Drugs; 2003 Mar; 14(3):193-202. PubMed ID: 12634613
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 14-3-3sigma gene silencing during melanoma progression and its role in cell cycle control and cellular senescence.
    Schultz J; Ibrahim SM; Vera J; Kunz M
    Mol Cancer; 2009 Jul; 8():53. PubMed ID: 19642975
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sensitizing hormone-refractory prostate cancer cells to drug treatment by targeting 14-3-3sigma.
    Han B; Xie H; Chen Q; Zhang JT
    Mol Cancer Ther; 2006 Apr; 5(4):903-12. PubMed ID: 16648560
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aberrant overexpression of an epithelial marker, 14-3-3sigma, in a subset of hematological malignancies.
    Motokura T; Nakamura Y; Sato H
    BMC Cancer; 2007 Nov; 7():217. PubMed ID: 18036248
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of epigenetic inactivation of 14-3-3sigma in human cancer.
    Lodygin D; Hermeking H
    Cell Res; 2005 Apr; 15(4):237-46. PubMed ID: 15857578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cooperative effect of p21Cip1/WAF-1 and 14-3-3sigma on cell cycle arrest and apoptosis induction by p14ARF.
    Hemmati PG; Normand G; Gillissen B; Wendt J; Dörken B; Daniel PT
    Oncogene; 2008 Dec; 27(53):6707-19. PubMed ID: 18806827
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypomethylation of the 14-3-3σ promoter leads to increased expression in non-small cell lung cancer.
    Radhakrishnan VM; Jensen TJ; Cui H; Futscher BW; Martinez JD
    Genes Chromosomes Cancer; 2011 Oct; 50(10):830-6. PubMed ID: 21755566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aberrant stratifin overexpression is regulated by tumor-associated CpG demethylation in lung adenocarcinoma.
    Shiba-Ishii A; Noguchi M
    Am J Pathol; 2012 Apr; 180(4):1653-62. PubMed ID: 22310466
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell type-specific methylation of an intronic CpG island controls expression of the MCJ gene.
    Strathdee G; Davies BR; Vass JK; Siddiqui N; Brown R
    Carcinogenesis; 2004 May; 25(5):693-701. PubMed ID: 14729589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differentiated keratinocyte-releasable stratifin (14-3-3 sigma) stimulates MMP-1 expression in dermal fibroblasts.
    Ghahary A; Marcoux Y; Karimi-Busheri F; Li Y; Tredget EE; Kilani RT; Lam E; Weinfeld M
    J Invest Dermatol; 2005 Jan; 124(1):170-7. PubMed ID: 15654971
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epigenetic silencing of 14-3-3sigma in cancer.
    Lodygin D; Hermeking H
    Semin Cancer Biol; 2006 Jun; 16(3):214-24. PubMed ID: 16698281
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential distribution of DNA methylation within the RASSF1A CpG island in breast cancer.
    Yan PS; Shi H; Rahmatpanah F; Hsiau TH; Hsiau AH; Leu YW; Liu JC; Huang TH
    Cancer Res; 2003 Oct; 63(19):6178-86. PubMed ID: 14559801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 14-3-3sigma, a p53 regulator, suppresses tumor growth of nasopharyngeal carcinoma.
    Yang H; Zhao R; Lee MH
    Mol Cancer Ther; 2006 Feb; 5(2):253-60. PubMed ID: 16505098
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.